Harmony Biosciences Holdings, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
714.38 |
844.14 |
990.59 |
1,141.80 |
1,367.74 |
1,549.07 |
| Przychód Δ r/r |
0.00% |
18.16% |
17.35% |
15.26% |
19.79% |
13.26% |
| Przychód (min) |
714.34 |
819.50 |
933.77 |
1,141.80 |
1,322.14 |
1,497.43 |
| Przychód (max) |
714.41 |
868.77 |
1,052.30 |
1,141.80 |
1,418.34 |
1,606.39 |
| EBITDA (średnia) |
199.00 |
235.14 |
275.93 |
318.05 |
380.99 |
431.50 |
| EBIT (średnia) |
162.60 |
192.13 |
225.46 |
259.88 |
311.30 |
352.57 |
| EBIT % |
22.76% |
22.76% |
22.76% |
22.76% |
22.76% |
22.76% |
| Zysk netto (średni) |
152.72 |
186.22 |
223.67 |
294.71 |
377.46 |
482.81 |
| Zysk netto % |
21.38% |
22.06% |
22.58% |
25.81% |
27.60% |
31.17% |
| EPS (średnia) |
2.36 |
3.22 |
3.99 |
4.85 |
6.52 |
8.34 |
| Liczba analityków (Przychody) |
6 |
6 |
11 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
6 |
3 |
7 |
9 |
4 |
3 |
| symbol |
HRMY |
HRMY |
HRMY |
HRMY |
HRMY |
HRMY |